Franklin Resources’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10,000
Closed -$52K 1596
2019
Q2
$52K Buy
+10,000
New +$44.9K ﹤0.01% 1536
2019
Q1
Sell
-5,528,361
Closed -$33.9M 1555
2018
Q4
$33.9M Sell
5,528,361
-453,805
-8% -$2.77M 0.02% 570
2018
Q3
$34.9M Sell
5,982,166
-25,354
-0.4% -$127K 0.02% 626
2018
Q2
$25.5M Buy
6,007,520
+38,149
+0.6% +$192K 0.01% 706
2018
Q1
$26.3M Buy
5,969,371
+28,969
+0.5% +$129K 0.01% 705
2017
Q4
$31.2M Sell
5,940,402
-149,158
-2% -$913K 0.02% 677
2017
Q3
$37.3M Buy
6,089,560
+78,251
+1% +$495K 0.02% 619
2017
Q2
$43.5M Buy
6,011,309
+604,518
+11% +$3.72M 0.02% 573
2017
Q1
$28.7M Buy
5,406,791
+19,992
+0.4% +$135K 0.01% 692
2016
Q4
$38.7M Sell
5,386,799
-3,930
-0.1% -$31.8K 0.02% 596
2016
Q3
$50.5M Sell
5,390,729
-19,462
-0.4% -$162K 0.03% 519
2016
Q2
$34.2M Sell
5,410,191
-11,358
-0.2% -$73K 0.02% 643
2016
Q1
$29.9M Buy
5,421,549
+1,037,646
+24% +$3.9M 0.02% 691
2015
Q4
$24.5M Buy
4,383,903
+422,427
+11% +$2.79M 0.01% 773
2015
Q3
$33.5M Buy
3,961,476
+161,634
+4% +$2.74M 0.02% 693
2015
Q2
$57.5M Buy
3,799,842
+373,965
+11% +$5.4M 0.03% 554
2015
Q1
$54.8M Buy
3,425,877
+101,871
+3% +$1.81M 0.02% 564
2014
Q4
$59.2M Sell
3,324,006
-44,913
-1% -$560K 0.03% 542
2014
Q3
$33.8M Buy
3,368,919
+723,615
+27% +$8.77M 0.02% 719
2014
Q2
$41.3M Buy
2,645,304
+1,052,147
+66% +$14.9M 0.02% 669
2014
Q1
$29.6M Buy
1,593,157
+1,565,305
+5,620% +$31.4M 0.01% 756
2013
Q4
$533K Buy
+27,852
New +$565K ﹤0.01% 1391

Other funds holding PETX

Franklin Resources's PETX Position: Q3 2019 in Review

Franklin Resources sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 10,000 shares — an estimated $52K sold.

Franklin Resources first reported a position in PETX in Q4 2013 and held it in 22 quarters. The position peaked at $59.2M in Q4 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Franklin Resources reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Franklin Resources sold 10,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $52K.
  • Franklin Resources first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 22 quarters.
  • Franklin Resources's Aratana Therapeutics, Inc. position peaked at $59.2M in Q4 2014.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Franklin Resources's 13F filing for Q3 2019, filed 14 Nov 2019.